Total Funding
75
67
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
51241
Artificial Intelligence algorithms in the field of pathology (Medical Software, SaaS model)
Wouter Bulten: Co-founder and Chief Innovation OfficerPast Role: Radboudumc REshape Center, Postdoctoral Researcher- David Tellez: Co-founder and Chief Technology OfficerPast Role: Radboudumc REshape Center, Postdoctoral Researcher
About the Company
Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancer
and CKD drug development studies for biopharma.
